- Home
- MIST vs ZTO Comparison
MIST vs ZTO Comparison
Compare MIST & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ZTO
- Stock Information
- Founded
- MIST 2003
- ZTO 2002
- Country
- MIST Canada
- ZTO China
- Employees
- MIST N/A
- ZTO N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ZTO Advertising
- Sector
- MIST Health Care
- ZTO Consumer Discretionary
- Exchange
- MIST Nasdaq
- ZTO Nasdaq
- Market Cap
- MIST 53.9M
- ZTO N/A
- IPO Year
- MIST N/A
- ZTO 2016
- Fundamental
- Price
- MIST $1.24
- ZTO $18.77
- Analyst Decision
- MIST Strong Buy
- ZTO Buy
- Analyst Count
- MIST 2
- ZTO 4
- Target Price
- MIST $9.50
- ZTO $25.13
- AVG Volume (30 Days)
- MIST 2.0M
- ZTO 2.8M
- Earning Date
- MIST 05-12-2025
- ZTO 05-20-2025
- Dividend Yield
- MIST N/A
- ZTO 3.65%
- EPS Growth
- MIST N/A
- ZTO N/A
- EPS
- MIST N/A
- ZTO 1.12
- Revenue
- MIST N/A
- ZTO $6,066,599,984.00
- Revenue This Year
- MIST N/A
- ZTO $18.23
- Revenue Next Year
- MIST N/A
- ZTO $12.96
- P/E Ratio
- MIST N/A
- ZTO $17.10
- Revenue Growth
- MIST N/A
- ZTO 15.26
- 52 Week Low
- MIST $0.63
- ZTO $16.34
- 52 Week High
- MIST $2.75
- ZTO $27.50
- Technical
- Relative Strength Index (RSI)
- MIST 53.98
- ZTO 46.92
- Support Level
- MIST $1.09
- ZTO $18.48
- Resistance Level
- MIST $1.37
- ZTO $19.29
- Average True Range (ATR)
- MIST 0.10
- ZTO 0.62
- MACD
- MIST 0.10
- ZTO 0.10
- Stochastic Oscillator
- MIST 89.28
- ZTO 67.74
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).